Safety profile of the lopinavir/ritonavir combination before and during the SARS-CoV-2 pandemic

Pauline Lory1, Sandrine Combret1, Joelle Michot2

  • 1Regional Pharmacovigilance Center, Dijon University Hospital, 21079 Dijon, France.

Therapie
|November 14, 2022
PubMed
Abstract

Insights

Lopinavir/ritonavir, used for COVID-19, showed different adverse drug reactions (ADRs) compared to its HIV treatment use. COVID-19 patients experienced more liver, heart, and kidney issues, unlike earlier gastrointestinal and skin reactions.

Area of Science:

  • Pharmacovigilance and drug safety research.
  • Infectious diseases and public health.
  • Clinical pharmacology and therapeutics.

Background:

  • No established treatments for SARS-CoV-2 existed at the pandemic's start.
  • Lopinavir/ritonavir, an HIV medication, was recommended for COVID-19 in France.
  • Early identification of adverse drug reactions (ADRs) was crucial.

Purpose of the Study:

  • To compare ADRs of lopinavir/ritonavir in COVID-19 patients versus its standard HIV indication.
  • To analyze safety signals identified through pharmacovigilance.

Main Methods:

  • Extracted ADR cases from the French Pharmacovigilance Database.
  • Compared ADRs reported during pre-COVID (1985-2019) and COVID (2020) periods.

Main Results:

  • COVID-19 patients showed significantly more liver (43%), heart (10.6%), and kidney (7.1%) damage.
  • Pre-pandemic ADRs were primarily gastrointestinal and cutaneous.
  • A distinct safety profile emerged for lopinavir/ritonavir in COVID-19.

Conclusions:

  • The altered safety profile may stem from SARS-CoV-2 effects, patient factors, or co-medications.
  • Drug safety profiles can vary based on therapeutic use.
  • Pharmacovigilance is vital for detecting new ADRs with established drugs.

Related Concept Videos

Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
79
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.3K
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.6K
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
957
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.5K
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
3.9K